Companion Animal Pharmaceuticals Market
Companion Animal Pharmaceuticals Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By Animal (Dogs, Cats, Horses); By Route of Administration (Oral, Injectable, Topical); By Product (Antibiotics, Anti-Inflammatory, Parasiticides, Vaccines); By Region (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)
- Published Date: May 2023
- Report ID: BWC23375
- Available Format: PDF
- Page: 400
Report Overview
Growing awareness about animal health and wellness, increasing pet ownership and humanization of pets, and adoption of advancements in veterinary healthcare technology are projected to propel the expansion of the global companion animal pharmaceuticals market during the forecast period between 2023 and 2029.Global Companion Animal Pharmaceuticals Market - Industry Trends & Forecast Report, 2029
The global companion animal pharmaceuticals market size was estimated at USD 34.8 billion in 2022. During the forecast period between 2023 and 2029, the size of global companion animal pharmaceuticals market is projected to grow at a CAGR of 4.42% reaching a value of USD 45.12 billion by 2029. Major growth drivers for the global companion animal pharmaceuticals market include an increasing number of pet adoptions, the rising prevalence of pet diseases, and the growing awareness of the importance of pet health. Also, a surge in demand for pet insurance owing to the rising expenditure on animal health, escalating investments in research and development (R&D) for animal healthcare, and high rates of pet ownership across the globe are expected to further drive the global market during the period in analysis.
Global Companion Animal Pharmaceuticals Market – Overview
A companion animal differs from an assistive animal in that it does not receive any specific training to help a person with a disability. Instead, companion animals provide humans with companionship, entertainment, emotional support, and other functions that humans need from animals. Veterinarians who specialize in companion animals can perform a range of medical services, including treating injuries and illnesses, performing surgeries, administering vaccines, and prescribing medications. They are also responsible for euthanizing animals when necessary. The owners of companion animals are responsible for the animal's well-being, actions, and care. When choosing a companion animal, it is essential to consider the owner's lifestyle, budget, and ability to provide proper care throughout the animal's life. Animal health products, such as feeds, are the most commonly used products for animal healthcare, and this market includes pharmaceuticals and vaccines that improve the health and welfare of animals. Animals obtain nutrition from these products. In recent years, the number of people who own and spend money on companion animals has increased, and pet owners now spend more money per pet than in the past. Pet owners prioritize their pet's health and wellness and expect them to live healthy lifestyles.
Global Companion Animal Pharmaceuticals Market
Growth Drivers
Rising Awareness about Animal Health and Wellness
The rising awareness about animal health and wellness is driving the demand for companion animal pharmaceutical products. Pet owners are increasingly concerned about the health and well-being of their pets and are willing to spend more money on their care. It has led to a significant increase in demand for animal health products, including pharmaceuticals and vaccines. As pet ownership rates continue to rise worldwide, the market for companion animal pharmaceuticals is expected to grow. Pet owners are becoming more aware of the importance of preventative care for their pets, which includes regular check-ups, vaccinations, and treatments for common health issues. In addition, the increasing prevalence of chronic diseases in animals has also contributed to the growth of the market. Companion animal pharmaceuticals are used to treat a wide range of illnesses and conditions, including arthritis, cancer, diabetes, and heart disease. Furthermore, the growing trend of humanization of pets has also driven the demand for high-quality healthcare products and services for companion animals. Pet owners are increasingly treating their pets as members of the family, which has led to a higher demand for products and services that support their pets' health and well-being.
Restraints
Stringent Regulations and Lengthy Approval Processes for Animal Pharmaceutical Products
The growth of the companion animal pharmaceuticals market may be hindered by stringent regulations and lengthy approval processes for animal pharmaceutical products. Animal health products are subject to extensive testing and regulatory requirements before they can be approved for commercial use. The approval process for animal health products can be lengthy and costly, which can limit the availability of new and innovative treatments for pets. This can lead to a slow adoption of new animal health products and limit the growth of the companion animal pharmaceuticals market. Also, the costs associated with compliance with these regulations may lead to an increase in the prices of animal health products, which could further limit their accessibility to pet owners.
Impact of COVID-19 on Global Companion Animal Pharmaceuticals Market
COVID-19 pandemic had a dual impact on the global companion animal pharmaceuticals market. On the positive side, with lockdowns and social distancing measures in place, people were spending more time at home and turning to pets for comfort and companionship. It led to an increase in pet ownership and a surge in demand for animal healthcare products and services, including pharmaceuticals. However, on the negative side, the pandemic disrupted global supply chains and manufacturing activities, causing shortages of raw materials and finished products. It led to production delays and increased prices, which affected the profitability of the market players. Moreover, with the focus on human healthcare during the pandemic, veterinary care and services were deprioritized in some regions, leading to a decline in demand for companion animal pharmaceuticals. Despite these challenges, the overall impact of the pandemic on the companion animal pharmaceuticals market was relatively moderate, and the market is expected to recover as the situation normalizes. As people continue to value the companionship of their pets, the demand for animal healthcare products and services is expected to remain robust in the long term.
Global Companion Animal Pharmaceuticals Market
Segmental Coverage
Global Companion Animal Pharmaceuticals Market – By Animal
By animal, the global companion animal pharmaceuticals market is divided into Dogs, Cats, and Horses segments. The dogs segment held the highest share in the global companion animal pharmaceuticals market in 2020. According to Holland Insurance Company Pty. Ltd., India is experiencing an exponential growth in its pet dog population, driven by urbanization and millennials opting for dogs as pets. Also, the growing awareness of pet insurance and animal health importance is expected to boost market growth. On the other hand, the cats’ segment is projected to have the highest compound annual growth rate (CAGR) during the forecast period. Cats are becoming increasingly popular in certain countries like Canada and are preferred over dogs. Additionally, many companies are concentrating on expanding their product range for cats due to their greater susceptibility to diseases when compared to other pets.
Global Companion Animal Pharmaceuticals Market – By Route of Administration
Based on route of administration, the global companion animal pharmaceuticals market is divided into Oral, Injectable, and Topical segments. The oral segment holds the highest share in the global companion animal pharmaceuticals market. Oral medications are easy to administer and do not require a trained professional to give the medication, which makes it more convenient for pet owners. They are often available in a variety of forms, such as tablets, capsules, and liquids, which can be mixed with food or treats to make administration easier. This versatility allows for a wider range of medications to be given orally. Also, oral medications often have a longer shelf life and do not require refrigeration, which can make storage and distribution more efficient for manufacturers and suppliers.
Global Companion Animal Pharmaceuticals Market – By Product
Based on product, the global companion animal pharmaceuticals market is divided into Antibiotics, Anti-Inflammatory, Parasiticides, and Vaccines segments. The parasiticides segment holds the highest share in the global companion animal pharmaceuticals market, due to the high prevalence of parasitic infections in companion animals. Parasites, such as fleas, ticks, and heartworms, can cause serious health issues in pets and even transmit diseases to humans. As a result, pet owners are increasingly seeking preventive measures, such as the use of parasiticides, to protect their pets from these parasites. Additionally, the development of new and more effective parasiticide products is driving market growth in this segment. Meanwhile, the vaccines segment holds the second highest share in the global companion animal pharmaceuticals market because vaccines play a crucial role in preventing infectious diseases in companion animals. Vaccinations are an essential part of the animal healthcare routine, and regular vaccination schedules are recommended to prevent the spread of diseases. Moreover, the increasing awareness about the importance of vaccination among pet owners and the rising incidence of zoonotic diseases are also driving the demand for animal vaccines. The COVID-19 pandemic has also accelerated the demand for animal vaccines, with many pet owners seeking to protect their pets from the virus.
Global Companion Animal Pharmaceuticals Market – By Region
The in-depth research report on the global companion animal pharmaceuticals market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America held the highest market share, due to the increasing number of pets, greater pet expenditure, and the trend towards pet humanization. Also, there has been a significant increase in pets receiving medical care, particularly for cats, following the start of the COVID-19 pandemic. Meanwhile, the Asia-Pacific region is projected to record the fastest growth rate during the forecast period driven by the growing pet ownership and increased awareness of pet health and treatment. In India, insurance companies are offering pet insurance to meet the demand for quality and affordable pet care, and to cater to the needs of modern-day pet parents, particularly those owning rare and foreign breeds. It is expected to propel regional market growth, with major general insurance companies, such as Bajaj Allianz, New India Assurance, Vetina Pawtect, and Oriental Insurance, offering pet insurance in the country.
Competitive Landscape
Major players operating in the global companion animal pharmaceuticals market include Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Virbac, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Santé Animale, Kindred Biosciences, Inc., Norbrook, IDEXX Laboratories, Inc., Animalcare Group plc, Neogen Corporation, and Heska Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
Recent Developments
-
In November 2022 - Virbac, a United States-based global leading provider of products focusing on companion animals, introduced a new joint supplement for dogs, MOVOFLEX, in Europe.
-
In January 2022 - Zoetis obtained approval from the US FDA for its chewable tablets, Simparica Trio (sarolaner, moxidectin, and pyrantel), which now includes a new label indication for the prevention of Borrelia burgdorferi infections in dogs.
Scope of the Report
Attributes |
Details |
Years Considered |
Historical Data – 2019–2022 |
Base Year – 2022 |
|
Estimated Year – 2023 |
|
Forecast Period – 2023–2029 |
|
Facts Covered |
Revenue in USD Billion |
Market Coverage |
North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
Product/ Service Segmentation |
Animal, Route of Administration, Product |
Key Players |
Zoetis Inc., Merck Animal Health, Boehringer Ingelheim International GmbH, Elanco Animal Health Incorporated, Bayer AG, Virbac, Dechra Pharmaceuticals PLC, Vetoquinol SA, Ceva Santé Animale, Kindred Biosciences, Inc., Norbrook, IDEXX Laboratories, Inc., Animalcare Group plc, Neogen Corporation, Heska Corporation |
By Animal
-
Dogs
-
Cats
-
Horses
By Route of Administration
-
Oral
-
Injectable
-
Topical
By Product
-
Antibiotics
-
Anti-Inflammatory
-
Parasiticides
-
Vaccines
By Region
-
North America
-
Europe
-
Asia Pacific (APAC)
-
Latin America
-
Middle East and Africa (MEA)
- Research Framework
- Research Objective
- Product Overview
- Market Segmentation
- Executive Summary
- Global Companion Animal Pharmaceuticals Market Insights
- Industry Value Chain Analysis
- DROC Analysis
- Growth Drivers
- Growing pet ownership and increasing humanization of pets
- Rising awareness about animal health and wellness
- Advancements in veterinary healthcare technology
- Restraints
- Stringent regulations and lengthy approval processes for animal pharmaceuticals
- High costs associated with veterinary drugs and treatments
- Opportunities
- Increasing demand for personalized and customized medicine for pets
- Rising trend of pet insurance, providing financial assistance for pet healthcare
- Challenges
- Concerns over the safety and efficacy of animal pharmaceuticals
- Lack of awareness and education about pet healthcare in certain regions
- Growth Drivers
- Product Advancements/Recent Developments
- Regulatory Framework
- Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
- Global Companion Animal Pharmaceuticals Market Overview
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share and Forecast
- By Animal
- Dogs
- Cats
- Horses
- Others
- By Route of Administration
- Oral
- Injectable
- Topical
- By Product
- Antibiotics
- Anti-inflammatory
- Parasiticides
- Vaccines
- Others
- By Region
- North America
- Europe
- Asia Pacific (APAC)
- Latin America (LATAM)
- Middle East and Africa (MEA)
- By Animal
- Market Size & Forecast, 2019–2029
- North America Companion Animal Pharmaceuticals Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Animal
- By Route of Administration
- By Product
- By Country
- United States
- By Animal
- By Route of Administration
- By Product
- Canada
- By Animal
- By Route of Administration
- By Product
- United States
- Market Size & Forecast, 2019–2029
- Europe Companion Animal Pharmaceuticals Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Animal
- By Route of Administration
- By Product
- By Country
- Germany
- By Animal
- By Route of Administration
- By Product
- United Kingdom
- By Animal
- By Route of Administration
- By Product
- Italy
- By Animal
- By Route of Administration
- By Product
- France
- By Animal
- By Route of Administration
- By Product
- Spain
- By Animal
- By Route of Administration
- By Product
- Belgium
- By Animal
- By Route of Administration
- By Product
- Russia
- By Animal
- By Route of Administration
- By Product
- The Netherlands
- By Animal
- By Route of Administration
- By Product
- Rest of Europe
- By Animal
- By Route of Administration
- By Product
- Germany
- Market Size & Forecast, 2019–2029
- Asia-Pacific Companion Animal Pharmaceuticals Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Animal
- By Route of Administration
- By Product
- By Country
- China
- By Animal
- By Route of Administration
- By Product
- India
- By Animal
- By Route of Administration
- By Product
- Japan
- By Animal
- By Route of Administration
- By Product
- South Korea
- By Animal
- By Route of Administration
- By Product
- Australia & New Zealand
- By Animal
- By Route of Administration
- By Product
- Indonesia
- By Animal
- By Route of Administration
- By Product
- Malaysia
- By Animal
- By Route of Administration
- By Product
- Singapore
- By Animal
- By Route of Administration
- By Product
- Vietnam
- By Animal
- By Route of Administration
- By Product
- Rest of APAC
- By Animal
- By Route of Administration
- By Product
- China
- Market Size & Forecast, 2019–2029
- Latin America Companion Animal Pharmaceuticals Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Animal
- By Route of Administration
- By Product
- By Country
- Brazil
- By Animal
- By Route of Administration
- By Product
- Mexico
- By Animal
- By Route of Administration
- By Product
- Argentina
- By Animal
- By Route of Administration
- By Product
- Peru
- By Animal
- By Route of Administration
- By Product
- Rest of LATAM
- By Animal
- By Route of Administration
- By Product
- Brazil
- Market Size & Forecast, 2019–2029
- Middle East & Africa Companion Animal Pharmaceuticals Market
- Market Size & Forecast, 2019–2029
- By Value (USD Million)
- Market Share & Forecast
- By Animal
- By Route of Administration
- By Product
- By Country
- Saudi Arabia
- By Animal
- By Route of Administration
- By Product
- UAE
- By Animal
- By Route of Administration
- By Product
- Qatar
- By Animal
- By Route of Administration
- By Product
- Kuwait
- By Animal
- By Route of Administration
- By Product
- South Africa
- By Animal
- By Route of Administration
- By Product
- Nigeria
- By Animal
- By Route of Administration
- By Product
- Algeria
- By Animal
- By Route of Administration
- By Product
- Rest of MEA
- By Animal
- By Route of Administration
- By Product
- Saudi Arabia
- Market Size & Forecast, 2019–2029
- Competitive Landscape
- List of Key Players and Their Offerings
- Global Companion Animal Pharmaceuticals Market Share Analysis, 2022
- Competitive Benchmarking, By Operating Parameters
- Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
- Impact of Covid-19 on Global Companion Animal Pharmaceuticals Market
- Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
- Zoetis Inc.
- Merck Animal Health
- Boehringer Ingelheim International GmbH
- Elanco Animal Health Incorporated
- Bayer AG
- Virbac
- Dechra Pharmaceuticals PLC
- Vetoquinol SA
- Ceva Santé Animale
- Kindred Biosciences, Inc.
- Norbrook
- IDEXX Laboratories, Inc.
- Animalcare Group plc
- Neogen Corporation
- Heska Corporation
- Other Prominent Players
- Key Strategic Recommendations
- Research Methodology
- Qualitative Research
- Primary & Secondary Research
- Quantitative Research
- Market Breakdown & Data Triangulation
- Secondary Research
- Primary Research
- Breakdown of Primary Research Respondents, By Region
- Assumptions & Limitations
- Qualitative Research
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable
List of Figures
Figure 1 Global Companion Animal Pharmaceuticals Market Segmentation
Figure 2 Global Companion Animal Pharmaceuticals Market Value Chain Analysis
Figure 3 Company Market Share Analysis, 2022
Figure 4 Global Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 5 Global Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 6 Global Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 7 Global Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 8 Global Companion Animal Pharmaceuticals Market Share, By Region, By Value, 2019–2029
Figure 9 North America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 10 North America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 11 North America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 12 North America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 13 North America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Figure 14 United States Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 15 United States Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 16 United States Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 17 United States Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 18 Canada Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 19 Canada Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 20 Canada Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 21 Canada Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 22 Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 23 Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 24 Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 25 Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 26 Europe Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Figure 27 Germany Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 28 Germany Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 29 Germany Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 30 Germany Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 31 United Kingdom Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 32 United Kingdom Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 33 United Kingdom Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 34 United Kingdom Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 35 Italy Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 36 Italy Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 37 Italy Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 38 Italy Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 39 France Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 40 France Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 41 France Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 42 France Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 43 Spain Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 44 Spain Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 45 Spain Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 46 Spain Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 47 Belgium Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 48 Belgium Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 49 Belgium Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 50 Belgium Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 51 Russia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 52 Russia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 53 Russia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 54 Russia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 55 The Netherlands Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 56 The Netherlands Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 57 The Netherlands Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 58 The Netherlands Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 59 Rest of Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 60 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 61 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 62 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 63 Asia-Pacific Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 64 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 65 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 66 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 67 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Figure 68 China Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 69 China Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 70 China Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 71 China Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 72 India Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 73 India Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 74 India Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 75 India Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 76 Japan Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 77 Japan Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 78 Japan Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 79 Japan Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 80 South Korea Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 81 South Korea Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 82 South Korea Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 83 South Korea Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 84 Australia & New Zealand Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 85 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 86 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 87 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 88 Indonesia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 89 Indonesia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 90 Indonesia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 91 Indonesia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 92 Malaysia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 93 Malaysia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 94 Malaysia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 95 Malaysia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 96 Singapore Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 97 Singapore Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 98 Singapore Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 99 Singapore Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 100 Vietnam Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 101 Vietnam Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 102 Vietnam Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 103 Vietnam Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 104 Rest of APAC Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 105 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 106 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 107 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 108 Latin America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 109 Latin America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 110 Latin America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 111 Latin America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 112 Latin America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Figure 113 Brazil Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 114 Brazil Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 115 Brazil Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 116 Brazil Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 117 Mexico Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 118 Mexico Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 119 Mexico Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 120 Mexico Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 121 Argentina Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 122 Argentina Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 123 Argentina Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 124 Argentina Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 125 Peru Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 126 Peru Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 127 Peru Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 128 Peru Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 129 Rest of LATAM Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 130 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 131 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 132 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 133 Middle East & Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 134 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 135 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 136 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 137 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Figure 138 Saudi Arabia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 139 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 140 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 141 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 142 UAE Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 143 UAE Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 144 UAE Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 145 UAE Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 146 Qatar Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 147 Qatar Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 148 Qatar Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 149 Qatar Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 150 Kuwait Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 151 Kuwait Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 152 Kuwait Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 153 Kuwait Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 154 South Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 155 South Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 156 South Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 157 South Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 158 Nigeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 159 Nigeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 160 Nigeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 161 Nigeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 162 Algeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 163 Algeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 164 Algeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 165 Algeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Figure 166 Rest of MEA Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Figure 167 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Figure 168 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Figure 169 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
List of Tables
Table 1 Global Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 2 Global Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 3 Global Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 4 Global Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 5 Global Companion Animal Pharmaceuticals Market Share, By Region, By Value, 2019–2029
Table 6 North America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 7 North America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 8 North America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 9 North America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 10 North America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Table 11 United States Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 12 United States Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 13 United States Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 14 United States Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 15 Canada Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 16 Canada Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 17 Canada Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 18 Canada Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 19 Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 20 Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 21 Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 22 Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 23 Europe Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Table 24 Germany Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 25 Germany Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 26 Germany Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 27 Germany Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 28 United Kingdom Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 29 United Kingdom Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 30 United Kingdom Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 31 United Kingdom Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 32 Italy Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 33 Italy Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 34 Italy Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 35 Italy Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 36 France Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 37 France Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 38 France Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 39 France Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 40 Spain Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 41 Spain Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 42 Spain Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 43 Spain Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 44 Belgium Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 45 Belgium Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 46 Belgium Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 47 Belgium Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 48 Russia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 49 Russia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 50 Russia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 51 Russia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 52 The Netherlands Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 53 The Netherlands Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 54 The Netherlands Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 55 The Netherlands Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 56 Rest of Europe Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 57 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 58 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 59 Rest of Europe Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 60 Asia-Pacific Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 61 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 62 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 63 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 64 Asia-Pacific Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Table 65 China Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 66 China Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 67 China Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 68 China Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 69 India Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 70 India Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 71 India Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 72 India Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 73 Japan Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 74 Japan Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 75 Japan Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 76 Japan Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 77 South Korea Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 78 South Korea Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 79 South Korea Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 80 South Korea Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 81 Australia & New Zealand Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 82 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 83 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 84 Australia & New Zealand Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 85 Indonesia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 86 Indonesia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 87 Indonesia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 88 Indonesia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 89 Malaysia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 90 Malaysia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 91 Malaysia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 92 Malaysia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 93 Singapore Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 94 Singapore Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 95 Singapore Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 96 Singapore Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 97 Vietnam Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 98 Vietnam Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 99 Vietnam Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 100 Vietnam Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 101 Rest of APAC Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 102 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 103 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 104 Rest of APAC Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 105 Latin America Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 106 Latin America Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 107 Latin America Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 108 Latin America Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 109 Latin America Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Table 110 Brazil Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 111 Brazil Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 112 Brazil Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 113 Brazil Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 114 Mexico Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 115 Mexico Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 116 Mexico Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 117 Mexico Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 118 Argentina Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 119 Argentina Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 120 Argentina Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 121 Argentina Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 122 Peru Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 123 Peru Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 124 Peru Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 125 Peru Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 126 Rest of LATAM Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 127 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 128 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 129 Rest of LATAM Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 130 Middle East & Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 131 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 132 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 133 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 134 Middle East & Africa Companion Animal Pharmaceuticals Market Share, By Country, By Value, 2019–2029
Table 135 Saudi Arabia Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 136 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 137 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 138 Saudi Arabia Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 139 UAE Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 140 UAE Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 141 UAE Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 142 UAE Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 143 Qatar Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 144 Qatar Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 145 Qatar Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 146 Qatar Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 147 Kuwait Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 148 Kuwait Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 149 Kuwait Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 150 Kuwait Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 151 South Africa Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 152 South Africa Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 153 South Africa Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 154 South Africa Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 155 Nigeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 156 Nigeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 157 Nigeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 158 Nigeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 159 Algeria Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 160 Algeria Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 161 Algeria Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 162 Algeria Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 163 Rest of MEA Companion Animal Pharmaceuticals Market Size, By Value (USD Million), 2019–2029
Table 164 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Animal, By Value, 2019–2029
Table 165 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Route of Administration, By Value, 2019–2029
Table 166 Rest of MEA Companion Animal Pharmaceuticals Market Share, By Product, By Value, 2019–2029
Table 167 Zoetis Inc. Company Overview
Table 168 Zoetis Inc. Financial Overview
Table 169 Merck Animal Health Company Overview
Table 170 Merck Animal Health Financial Overview
Table 171 Boehringer Ingelheim International GmbH Company Overview
Table 172 Boehringer Ingelheim International GmbH Financial Overview
Table 173 Elanco Animal Health Incorporated Company Overview
Table 174 Elanco Animal Health Incorporated Financial Overview
Table 175 Bayer AG Company Overview
Table 176 Bayer AG Financial Overview
Table 177 Virbac Company Overview
Table 178 Virbac Financial Overview
Table 179 Dechra Pharmaceuticals PLC Company Overview
Table 180 Dechra Pharmaceuticals PLC Financial Overview
Table 181 Vetoquinol SA Company Overview
Table 182 Vetoquinol SA Financial Overview
Table 183 Ceva Santé Animale Company Overview
Table 184 Ceva Santé Animale Financial Overview
Table 185 Kindred Biosciences, Inc. Company Overview
Table 186 Kindred Biosciences, Inc. Financial Overview
Table 187 Norbrook Company Overview
Table 188 Norbrook Financial Overview
Table 189 IDEXX Laboratories, Inc. Company Overview
Table 190 IDEXX Laboratories, Inc. Financial Overview
Table 191 Animalcare Group plc Company Overview
Table 192 Animalcare Group plc Financial Overview
Table 193 Neogen Corporation Company Overview
Table 194 Neogen Corporation Financial Overview
Table 195 Heska Corporation Company Overview
Table 196 Heska Corporation Financial Overview
Market Segmentation
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
Frequently Asked Questions (FAQs):
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research Support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Custom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.